Gara Jalqabaatti › Baayyee Ulfaataa › Texas › Dallas
Qorannoo klinikaalii Baayyee Ulfaataa Dallas, TX keessatti
Qorannoo 20 Baayyee Ulfaataa f Dallas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 2
- Velocity Clinical Research - Dallas /ID# 282734, Dallas
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- UT Southwestern Med Center, Dallas
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- North Texas Endocrine Center, Dallas
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Namoota walitti qabaa jiraSadarkaa 3
- UT Southwestern Med Center, Dallas
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Cedar Health Research - Texas Native Health, Dallas
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Velocity Clinical Research, Dallas, Dallas
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Namoota walitti qabaa jiraSadarkaa 3
- UT Southwestern Medical Center, Dallas
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Thyroid Endocrinology and Diabetes, Dallas
- Soltero Cardiovascular Research Center, Dallas
- Zenos Clinical Research, Dallas
- fi 2 dabalataa
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Velocity Clinical Research, Dallas, Dallas
- UT Southwestern Medical Center, Dallas
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- FutureSearch Trials of Dallas, Dallas
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Velocity Clinical Research, Dallas
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Namoota walitti qabaa jiraSadarkaa 3
- Cedar Health Research, Dallas
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Velocity Clinical Research, Dallas, Dallas
- FutureSearch Trials of Dallas, Dallas
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 2
- Mercy Family Clinic, Dallas
- Velocity Clinical Research, Dallas, Dallas
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Namoota walitti qabaa jiraSadarkaa 4
- Modern Research Associates, PLLC, Dallas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Cedar Health Research, LLC, Dallas
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Namoota walitti qabaa jiraSadarkaa 3
- Mercy Family Clinic, Dallas
Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program
Namoota walitti qabaa jira
- University of Texas Southwestern, Children's Health, Dallas
Healthy Living BEYOND Weight Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- American Heart Association, Dallas
Qorannoo Baayyee Ulfaataa magaalota biroo keessatti
- San Antonio, TXQorannoo 34
- Houston, TXQorannoo 33
- Chicago, ILQorannoo 28
- Orlando, FLQorannoo 27
- Las Vegas, NVQorannoo 23
- Miami, FLQorannoo 23
- Atlanta, GAQorannoo 20
- New York City, NYQorannoo 19
- Jacksonville, FLQorannoo 19
- Washington, DCQorannoo 19
- Austin, TXQorannoo 18
- Baltimore, MDQorannoo 17
Qorannoo biroo Dallas keessatti
- Saree OljooQorannoo 55
- Kansara Qara'a Non-Small CellQorannoo 52
- Kansara MetastatikiiQorannoo 42
- Cufama OnneeQorannoo 42
- Saree (Gosoota Hunda)Qorannoo 37
- Kansarii ProstateQorannoo 36
- Kansarii ColorectalQorannoo 33
- ObesityQorannoo 30
- Kansarii OvariiQorannoo 28
- Dukkana BladderQorannoo 27
- Dhibee QaraQorannoo 27
- Kansa EndometiriyaaliiQorannoo 24
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.